Skip to main content

Albert Blanco Grau

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Albert Blanco Grau

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Research lines

Análisis bioinformático masivo

IP: Albert Blanco Grau, Luisa Maria Martinez Sánchez

Projects

Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT)

IP: -
Collaborators: José Antonio Arranz Amo, Raquel Barquin Del Pino, Laura Conesa Milian, Clara Ramírez Serra, Yolanda Villena Ortiz, Joan López Hellin, Albert Blanco Grau, Roser Ferrer Costa, Joaquin Seras Franzoso, Diego Baranda Martínez-Abasca, Laura Castillo Ribelles, Clara Carnicer Cáceres, Marina Giralt Arnaiz, Ana Gomez Garcia, Simon Schwartz Navarro, Pablo Gabriel Medina, Zamira Vanessa Diaz Riascos, Marc Miquel Moltó Abad, Laura Castellote Bellés, Daniel Bravo Nieto, Luz María Cruz Carlos, Clara Sanz Gea, Alba Estela García Fernández, Maria del Pilar Reimundo Diaz-Fierros, Belen Garcia Prats, Noelia Díaz Troyano, JAUME VIMA BOFARULL, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Maria Francesca Cortese, Sandra Mancilla Zamora
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 01173
Duration: 01/01/2022 - 30/06/2025

COVID-19, PERFIL INMUNOLÓGICO DE RIESGO

IP: -
Collaborators: Manuel Hernández González, Mónica Martínez Gallo, Moisés Labrador Horrillo, Gema Codina Grau, Albert Blanco Grau, Andres Antón Pagarolas, Antonio Álvarez Fernandez, Nuria Fernández Hidalgo, Roser Ferrer Costa, Esteve Ribera Pascuet, Juan Carlos Ruiz Rodriguez, Jaume Ferrer Sancho, Anna Suy Franch, Pere Soler Palacín, Albert Selva O'Callaghan, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Daniel Alvarez De la Sierra, Andrea Martín Nalda, Eva Polverino, Romina Dieli Crimi, Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 229000
Reference: COV20/00416
Duration: 08/05/2020 - 08/11/2021

Abordaje genético-molecular de enfermedades mitocondriales del sistema OXPHOS: identificación de factores condicionantes del fenotipo.

IP: Elena García Arumí
Collaborators: Albert Blanco Grau, Mª Jesus Melia Grimal, Paula Fernández Álvarez
Funding agency: Instituto de Salud Carlos III
Funding: 212052.5
Reference: PI15/01428
Duration: 01/01/2016 - 30/06/2019

Patologia Neuromuscular i Mitocondrial (GRC)

IP: Ramon Martí Seves
Collaborators: Antonio Luis Andreu Périz, Elena García Arumí, Yolanda Cámara Navarro, Albert Blanco Grau, Mª Jesus Melia Grimal, Tomàs Pinós Figueras, Raquel Cabrera Perez
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 24000
Reference: 2014 SGR 842
Duration: 01/01/2014 - 31/12/2016

Related news

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Researchers from all over Europe gathered to kick off the SPM4.0 project, an innovative Marie Curie Skłodowska (MSCA-DN) doctoral network that promotes the development of autonomous Scanning Probe Microscopy with AI.

Related professionals

Jordi Sabadell García

Jordi Sabadell García

General Surgery
Read more
Maria Pinyol Sarrias

Maria Pinyol Sarrias

Junior researcher
Infection and immunity in pediatric patients
Read more
LUCIA RODRIGUEZ NEBOT

LUCIA RODRIGUEZ NEBOT

Tècnic/a Grau Superior
Clinical Trials Management Unit
Clinical Research Development Directorate
Read more
Adaia Albasanz Puig

Adaia Albasanz Puig

Postdoctoral researcher
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.